BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 31098627)

  • 21. Exosomes derived from miR-146a-modified adipose-derived stem cells attenuate acute myocardial infarction-induced myocardial damage via downregulation of early growth response factor 1.
    Pan J; Alimujiang M; Chen Q; Shi H; Luo X
    J Cell Biochem; 2019 Mar; 120(3):4433-4443. PubMed ID: 30362610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exosomes Derived from MicroRNA-146a-5p-Enriched Bone Marrow Mesenchymal Stem Cells Alleviate Intracerebral Hemorrhage by Inhibiting Neuronal Apoptosis and Microglial M1 Polarization.
    Duan S; Wang F; Cao J; Wang C
    Drug Des Devel Ther; 2020; 14():3143-3158. PubMed ID: 32821084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistance.
    Gyöngyösi M; Lukovic D; Zlabinger K; Spannbauer A; Gugerell A; Pavo N; Traxler D; Pils D; Maurer G; Jakab A; Riesenhuber M; Pircher A; Winkler J; Bergler-Klein J
    Cardiovasc Res; 2020 Apr; 116(5):970-982. PubMed ID: 31346605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overweight in mice, induced by perinatal programming, exacerbates doxorubicin and trastuzumab cardiotoxicity.
    Guenancia C; Hachet O; Aboutabl M; Li N; Rigal E; Cottin Y; Rochette L; Vergely C
    Cancer Chemother Pharmacol; 2016 Apr; 77(4):777-85. PubMed ID: 26914236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HDL protects against doxorubicin-induced cardiotoxicity in a scavenger receptor class B type 1-, PI3K-, and Akt-dependent manner.
    Durham KK; Chathely KM; Mak KC; Momen A; Thomas CT; Zhao YY; MacDonald ME; Curtis JM; Husain M; Trigatti BL
    Am J Physiol Heart Circ Physiol; 2018 Jan; 314(1):H31-H44. PubMed ID: 28986362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-19a-3p containing exosomes improve function of ischaemic myocardium upon shock wave therapy.
    Gollmann-Tepeköylü C; Pölzl L; Graber M; Hirsch J; Nägele F; Lobenwein D; Hess MW; Blumer MJ; Kirchmair E; Zipperle J; Hromada C; Mühleder S; Hackl H; Hermann M; Al Khamisi H; Förster M; Lichtenauer M; Mittermayr R; Paulus P; Fritsch H; Bonaros N; Kirchmair R; Sluijter JPG; Davidson S; Grimm M; Holfeld J
    Cardiovasc Res; 2020 May; 116(6):1226-1236. PubMed ID: 31410448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin.
    Yokoyama C; Aoyama T; Ido T; Kakino A; Shiraki T; Tanaka T; Nishigaki K; Hasegawa A; Fujita Y; Sawamura T; Minatoguchi S
    PLoS One; 2016; 11(5):e0154994. PubMed ID: 27195769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity.
    Lee KH; Cho H; Lee S; Woo JS; Cho BH; Kang JH; Jeong YM; Cheng XW; Kim W
    Int J Cardiol; 2017 Apr; 232():40-47. PubMed ID: 28159361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction.
    Barile L; Lionetti V; Cervio E; Matteucci M; Gherghiceanu M; Popescu LM; Torre T; Siclari F; Moccetti T; Vassalli G
    Cardiovasc Res; 2014 Sep; 103(4):530-41. PubMed ID: 25016614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with apolipoprotein A1 protects mice against doxorubicin-induced cardiotoxicity in a scavenger receptor class B, type I-dependent manner.
    Durham KK; Kluck G; Mak KC; Deng YD; Trigatti BL
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1447-H1457. PubMed ID: 31002281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Cardioprotective Role of Flaxseed in the Prevention of Doxorubicin- and Trastuzumab-Mediated Cardiotoxicity in C57BL/6 Mice.
    Asselin CY; Lam A; Cheung DYC; Eekhoudt CR; Zhu A; Mittal I; Mayba A; Solati Z; Edel A; Austria JA; Aukema HM; Ravandi A; Thliveris J; Singal PK; Pierce GN; Niraula S; Jassal DS
    J Nutr; 2020 Sep; 150(9):2353-2363. PubMed ID: 32510147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenously transplanted mesenchymal stromal cells: a new endocrine reservoir for cardioprotection.
    Huang A; Liu Y; Qi X; Chen S; Huang H; Zhang J; Han Z; Han ZC; Li Z
    Stem Cell Res Ther; 2022 Jun; 13(1):253. PubMed ID: 35715868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TNF-α-induced exosomal miR-146a mediates mesenchymal stem cell-dependent suppression of urethral stricture.
    Liang YC; Wu YP; Li XD; Chen SH; Ye XJ; Xue XY; Xu N
    J Cell Physiol; 2019 Dec; 234(12):23243-23255. PubMed ID: 31144307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of mesenchymal stem cells-derived exosomes on inflammation, apoptosis, fibrosis and telocyte modulation in doxorubicin-induced cardiotoxicity: A closer look at the structural level.
    Imam RAEN; Aboulhoda BE; Amer MM; Hassan FE; Alghamdi MA; Abdel-Hamed MR
    Microsc Res Tech; 2024 Jul; 87(7):1598-1614. PubMed ID: 38441397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway.
    Kim KH; Oudit GY; Backx PH
    J Pharmacol Exp Ther; 2008 Jan; 324(1):160-9. PubMed ID: 17928571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cortical bone stem cell-derived exosomes' therapeutic effect on myocardial ischemia-reperfusion and cardiac remodeling.
    Schena GJ; Murray EK; Hildebrand AN; Headrick AL; Yang Y; Koch KA; Kubo H; Eaton D; Johnson J; Berretta R; Mohsin S; Kishore R; McKinsey TA; Elrod JW; Houser SR
    Am J Physiol Heart Circ Physiol; 2021 Dec; 321(6):H1014-H1029. PubMed ID: 34623184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of miR-23a attenuates doxorubicin-induced mitochondria-dependent cardiomyocyte apoptosis by targeting the PGC-1α/Drp1 pathway.
    Du J; Hang P; Pan Y; Feng B; Zheng Y; Chen T; Zhao L; Du Z
    Toxicol Appl Pharmacol; 2019 Apr; 369():73-81. PubMed ID: 30831132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trastuzumab potentiates doxorubicin-induced cardiotoxicity via activating the NLRP3 inflammasome in vivo and in vitro.
    Wei S; Ma W; Yang Y; Sun T; Jiang C; Liu J; Zhang B; Li W
    Biochem Pharmacol; 2023 Aug; 214():115662. PubMed ID: 37331637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apoptosis-Resistant Cardiac Progenitor Cells Modified With Apurinic/Apyrimidinic Endonuclease/Redox Factor 1 Gene Overexpression Regulate Cardiac Repair After Myocardial Infarction.
    Aonuma T; Takehara N; Maruyama K; Kabara M; Matsuki M; Yamauchi A; Kawabe J; Hasebe N
    Stem Cells Transl Med; 2016 Aug; 5(8):1067-78. PubMed ID: 27334489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Docosahexaenoic Acid Attenuates Doxorubicin-induced Cytotoxicity and Inflammation by Suppressing NF-κB/iNOS/NO Signaling Pathway Activation in H9C2 Cardiac Cells.
    Wang ZQ; Chen MT; Zhang R; Zhang Y; Li W; Li YG
    J Cardiovasc Pharmacol; 2016 Apr; 67(4):283-9. PubMed ID: 26657886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.